Asian Journal of Transfusion Science
Home About Journal Editorial Board Search Current Issue Ahead of print Back Issues Instructions Subscribe Login  Users: 336 Print this page  Email this page Small font sizeDefault font sizeIncrease font size 

REVIEW ARTICLE Table of Contents   
Year : 2017  |  Volume : 11  |  Issue : 1  |  Page : 1-5
Blood transfusion safety; current status and challenges in Nigeria

Department of Haematology and Blood Transfusion, Nnamdi Azikiwe University, Nnewi Campus, Anambra State, Nigeria

Click here for correspondence address and email

Date of Submission10-Jan-2016
Date of Acceptance19-May-2016
Date of Web Publication22-Feb-2017


The attainment of blood transfusion safety in Nigeria (and probably the rest of Sub-Saharan Africa) remains an uphill task due to a number of factors, ranging from shortage of blood, poor implementation of blood transfusion guidelines, infrastructural deficits to high prevalence of transfusion-transmissible infections (TTIs), particularly hepatitis and human immune deficiency viruses. We reviewed available data on blood transfusion practices and safety in Nigeria using the PubMed, PubMed Central, Google Scholar, and African Index Medicus search engines, through a combination of word and phrases relevant to the subject. The World Health Organization has been in the forefront of efforts to establish safe, available, and affordable blood transfusion services in most parts of Africa through encouraging adequate blood donor recruitment, donor blood testing, and collection as well developing strategies for the rational use of blood. Even though modest improvement has been recorded, particularly with regards to donor blood screening for common TTIs, considerable efforts are needed in the form of robust public enlightenment campaigns (on blood donation) and continuous system improvement to drive the current transfusion practices in the country toward safety and self-sustenance.

Keywords: Blood safety, national blood policy, transfusion transmissible infections, voluntary blood donation

How to cite this article:
Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian J Transfus Sci 2017;11:1-5

How to cite this URL:
Aneke JC, Okocha CE. Blood transfusion safety; current status and challenges in Nigeria. Asian J Transfus Sci [serial online] 2017 [cited 2022 Nov 27];11:1-5. Available from:

Adequate blood supply and health indices

The World Health Organization (WHO) had projected that Sub-Saharan Africa will attain sustainable blood transfusion safety by the year 2012, through the implementation of sets of policies geared toward provision of safe, affordable, and readily available blood units in hospitals to serve the needs of patients.[1],[2] Up till now, however, this goal is far from achieved in Nigeria and a number of other African countries, with attendant negative impact on health indices. Effective healthcare delivery globally is known to be supported by a robust supply of safe blood units which could indeed be lifesaving in a number of clinical scenarios. Correspondingly, from the road traffic accident victim with acute hemorrhage at the emergency room to the obstetric patient with antepartum/postpartum hemorrhage or the under-five child presenting with anemic heart failure, prompt administration of appropriate units of blood could well make the difference between life and avoidable demise. Earlier, extensive inquests into the causes of the high maternal mortality in Nigeria and Sub-Saharan Africa had highlighted the huge contribution of the very ineffective blood transfusion services.[3],[4] The maternal mortality rate in Nigeria (630 deaths/100,000 live births) is unacceptably high and indeed ranks high among contemporary developing economies.[5] It is, therefore, instructive to emphasize that the expected improvement in the low health indices in Nigeria (particularly high maternal and infant mortalities) may continue unrealized until significant improvements take place in the country's blood transfusion services.We searched PubMed, PubMed Central, Google Scholar, and the African Index Medicus electronic databases, using a number of word and phrase combinations: “Blood safety,” “transfusion practices,” “blood donation,” “donor screening,” “transfusion-transmissible infections (TTIs)” “transfusion(s),” “developing countries,” and “Nigeria.” The information from these publications was discussed in this review and recommendations made based on identified gaps in efforts toward achieving blood transfusion safety in Nigeria.

   The National Blood Policy Top

Nigeria established a National blood transfusion policy through a published set of guidelines in December 2006. The publication was a fall-out of the baseline survey on blood transfusion practices which was earlier conducted in the country in August 2005. Salient conclusions from the survey included;[6]

  • Only half a million units of blood were collected from both private and public sources in 2004
  • At the time of the survey, blood need in Nigeria was estimated to be 1.5 million units
  • In the public sector, the donor population was made up of 25% commercial donors and 75% of replacement donors. Voluntary unpaid donors were negligible
  • In the private sector, the donor population was made up of 75% commercial donors and 25% of replacement donors. Voluntary unpaid donors were insignificant.

The National blood policy is essentially made up of sets of action plans which are all geared toward the provision of safe, available, and affordable blood donor units, where and when they might be needed in the country. It is structured into blood transfusion services under the following strata [Table 1]; (i) the national blood transfusion service (NBTS), (ii) the zonal blood service centers, (iii) state and local government areas blood service centers, (iv) the armed forces blood service, and (v) private and other nongovernmental health establishments.[6] The essence of the above stratification was to ensure universal coverage of the country, right to local government councils.
Table 1: Levels of organization and function of the National Blood Policy

Click here to view

Forms of blood donation in Nigeria

There are 3 main classifications of blood donors in Nigeria; the voluntary (nonremunerated) donors, family (replacement) donors and commercial (paid) donors.[7]

The voluntary donors are the altruistic individuals who donate blood with the sole aim of saving a life, without regard to any form of inducement. They are usually mobilized through the mass media or blood donation drives to schools, churches and mosques. An earlier study had hypothesized that the dearth of voluntary donors in Nigeria and Sub-Saharan Africa is probably associated with the fact that the mentality of altruism (regarding blood donation) is not yet generally accepted in the typical African culture, compared to what is obtainable in the most developed countries.[8]

The family (replacement) donors include those that donate for a hospitalized family member, friend, or associate and is largely nonremunerated, depending entirely on the good will of friends and family members. Osaro et al. had concluded that the continued importance of family donors in Sub-Saharan Africa could be linked to the fact that it may actually cost less to procure and is also well adapted to the extended family support system of many Nigerian and African communities.[8]

Persistent blood shortages coupled with increased poverty in Nigeria (and most African countries) created another population of donors who give blood strictly for financial gratification; these constitute the commercial (paid) donors. These have continued to increase in number and prominence in Nigeria, fuelled by the very huge deficit in blood supply and utilization. Ahmed et al. succinctly captured this phenomenon in a report among blood donors seen at the University of Maiduguri Teaching Hospital, Northeast Nigeria over a 12 years period.[7] They observed a progressive decrease in the percentage of voluntary blood donation, over the study period, from 31% to 5%, against an increase from 20% to 63% in the frequency of commercial blood donation.[7] The above study equally emphasized the wide gap between blood supply and demand in Nigeria by showing that the mean annual increment in the number of blood donations (4%) was well below the mean annual increment in in-patient numbers (11%).[7] Similarly, Emeribe et al. chronicled blood donation and distribution in a 400-bed teaching hospital in South-South Nigeria and reported that the general blood supply was unacceptably low, whereas the surgical departments (surgery and obstetrics and gynecology) utilized a larger pool of all donated blood (70.4%) over the study period of 4 years.[9] These observations unarguably show the blood donation dynamics and similarly offer some insight into the problems bedeviling the attainment of blood transfusion safety in the country, which is mainly poor supply of donor units. Commercial (paid) blood donors, therefore, flourished and thrived in this atmosphere of supply deficit, to the detriment of blood transfusion safety in the country.

   Current Status/challenges Top

High prevalence of transfusion-transmissible infections

The high prevalence of TTIs in blood donors and the general population in Nigeria has unarguably impacted negatively on blood transfusion safety. Indeed, prevalence rates as high as 18%, 23%, and 12.3% for the human immunodeficiency virus (HIV), hepatitis B virus and hepatitis C virus (HCV) respectively have been reported among prison inmates in Nasarawa, North-central Nigeria.[10] The prevalence rates of some TTIs across different parts of the country are shown in [Table 2].
Table 2: Prevalence of transfusion-transmissible infections among Nigerian population

Click here to view

High frequency of commercial blood donation

The WHO has consistently emphasized blood sourcing from voluntary, nonremunerated blood donors, due to their markedly reduced chances of harboring and transferring TTIs.[11] This recommendation has been reiterated and supported by an increasing body of evidence from Nigerian researchers.[12],[13],[14] Unfortunately, several studies in Nigeria in the last couple of years have shown that voluntary blood donors constituted but a small fraction of the blood donor pool, this obviously has grave implications for transfusion safety.[7], 9, [12],[13],[14] Allain, in his seminal work, chronicled the social demographic information of blood donors in Sub-Saharan Africa and reported that commercial blood donors were all males while the median ages of voluntary and family donors were 18 years and 30 years, respectively.[15] Similar studies in Nigeria had equally identified a male dominated donor pool as well as young adults as the predominant donor age group; these mirror the more active age and gender stratum of the Nigerian population.[13],[14] Unfortunately, this age distribution has also been associated with the highest carriage rates of TTIs (arising most probably from increased involvement in high-risk sexual behaviors and experimentation), this, therefore, poses a huge challenge to the country's efforts toward attaining blood transfusion safety.[16],[17],[18]

Supply deficits

According to the NBTS, Nigeria, with a population of over 150 million people uses about 1.5 million units of blood every year to cater for the health needs of its citizens.[6] This well approximates to far less than a pint of blood per person and further highlights a very poor blood supply chain in the country.[7],[9] It, therefore, implies that the present pool of mainly commercial blood and family donors cannot bridge the nation's blood supply deficits, in fact, poor blood supply is probably the key hindrance to the smooth operations of the National blood transfusion policy aimed toward boosting transfusion safety in the country.[6] A number of studies have shown why Nigerians will not voluntarily and regularly donate blood, as is obtainable in more developed countries. Olaiya et al. evaluated the attitude of individuals in Lagos (Southwest Nigeria) toward blood donation and identified a number of factors, ranging from fear of contacting TTIs (52.4%) to fear of side effects such as weight loss (23.8%), sudden death (3.3%), sexual failure (5.9%), high blood pressure (5.2%) and convulsions (1.5%) as impediments to blood donation.[19] A similar study in Calabar, South-South Nigeria identified diverse religious beliefs as the most common reason for refusal of blood donation.[20]

Donor unit screening

Current NBTS guideline mandates the screening of all donors units for anti HCV, hepatitis B surface antigen, anti HIV, and syphilis, using a combination of rapid qualitative immunochromatographic test kits, enzyme-linked immunosorbent assays and antigen assays.[6] While this is the practice in most of the blood banks in the country (particularly those attached to tertiary hospitals), however, nucleic acid tests (NATs) are not yet universally available for TTIs testing. NATs have the added advantage of increasing the detection of TTIs, especially during the window periods.[21]

Red cell sensitization

Multiple red cell transfusion could predispose to the formation of clinically significant titers of lytic antibodies which may cause hemolytic disease of the newborn (HDN) or hemolytic transfusion reactions.[22] Patients with hemoglobinopathies and others that require lifesaving regular blood transfusions are thus at a particularly high risk of red cell sensitization by alloantibodies. This remains a significant hindrance to transfusion safety in Nigeria, a situation that is further complicated by the fact that the means of investigating for fetomaternal bleeds and HDN prophylaxis for at-risk groups are not universally available.[8] The magnitude of red cell sensitization in Nigeria was highlighted in the independent reports of Ugwu (Benin City, Midwestern Nigeria), Kangiwa (Enugu, Southeast Nigeria), and Jeremiah (Port Harcourt, South-South Nigeria) in which prevalence rates of 9.3%, 18.7%, and 3.4%, respectively were observed in multiply transfused patient populations.[22],[23],[24]

Poor utilization of autologous blood transfusions

The use of autologous blood transfusion has been noted to improve transfusion safety as a result of the significantly reduced chances of blood transfusion reactions, red cell sensitization to alloantibodies and transmission of TTIs.[25] Studies in Nigeria showed that this practice is both a safe and cost effective way of improving blood supply and safety and therefore needs to be encouraged.[26],[27],[28] Obed et al. evaluated the rate of autologous blood transfusion at the University of Maiduguri Teaching Hospital, Maiduguri, Northeast Nigeria among Obstetric patients and reported an overall prevalence rate of 20.7%, out of which preoperative blood donation accounted for 95.8% whereas 6.4% of the units were predeposited.[27] The rate of autologous blood transfusion was even lower in a study conducted at Zaria, North Central Nigeria (0.58%).[28]

Intraoperative cell salvage which involves the aseptic collection of blood lost during or after surgical operations with the aim of re-infusing same into patients has been shown be a feasible way to reduce the risks associated with homologous blood transfusions in Nigeria.[29] This is particularly important in patients with blunt abdominal trauma or ruptured ectopic gestation. The practice of intraoperative cell salvage in Nigeria is low currently, a multicenter study that involved surgeons and anesthetics reported usage rate of just 0.01%.[30]

Erythropoietin use

Erythropoietin is a 30.4-kDa glycoprotein hormone produced by the kidney and liver which has a stimulant effect on erythropoiesis by inhibiting apoptosis of erythroid precursors, particularly at the colony-forming units-erythroid stage.[31] When given to appropriately selected patients, it has been found to significantly boost the hemoglobin concentration, thereby reducing the transfusion requirements during surgery. Udosen et al. had reported successful surgery facilitated by the use of erythropoietin resulting in hemoglobin concentration increase from 70 g/L to 140 g/L, over a period of 6 weeks, in a patient (of Jehovah's Witness faith) in Calabar, South-South Nigeria.[32] There is indeed paucity of report on the use of erythropoietin in Nigerian patients, and this most probably indicates that the practice is relatively unpopular.


Intense mass mobilization and campaign

Increasing the pool of voluntary blood donors in Nigeria is the key to bridging the blood supply gap and could translate into better blood transfusion safety. A number of studies have identified some factors that appear to hinder people from donating blood in the country, an intense campaign using the mass/social media is therefore recommended to counter these erroneous ingrained belief systems. More so, adequate emphasis should be given to voluntary blood donation and intensive education on the risks and means of acquiring TTIs (during such enlightenment campaigns) with a view to reversing the high dependence on commercial blood donation and reducing the high prevalence rates of TTIs.

Strengthening donor blood screening and cross-matching protocols

Donor blood screening should be further strengthened, while NATs should be made more universally available in the blood banks in the country. Moreover, antibody screening and identification should be made routine, particularly for at-risk groups.

Alternatives to homologous transfusions

Encouraging the use of autologous blood transfusion and erythropoietin could go a long way in reducing overdependence on homologous blood transfusion (along with the potential risks it possesses) and the frequency of transfusions in Nigeria.

   Conclusion Top

Urgent concerted action is needed in Nigeria to correct the blood supply deficit and increase the pool of voluntary (nonremunerated) blood donors. This is expected to significantly improve blood transfusion safety and positively impact on health indices in the country. More so, encouraging more universal use of autologous blood transfusion, intraoperative cell salvage and erythropoietin is imperative to reduce the huge demand on homologous blood.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.[39]

   References Top

Tagny CT, Mbanya D, Tapko JB, Lefrère JJ. Blood safety in sub-Saharan Africa: A multi-factorial problem. Transfusion 2008;48:1256-61.  Back to cited text no. 1
Tapko J, Mainuka P, Diarra-Nama AJ. Status of Blood Safety in the WHO African Region: Report of the 2006 Survey; 2006. Available from: health-technologies-a-laboratories.html. [Last accessed on 2015 Dec 02].  Back to cited text no. 2
Umeora OU, Onuh SO, Umeora MC. Socio-cultural barriers to voluntary blood donation for obstetric use in a rural Nigerian village. Afr J Reprod Health 2005;9:72-6.  Back to cited text no. 3
Bates I, Chapotera GK, McKew S, van den Broek N. Maternal mortality in sub-Saharan Africa: The contribution of ineffective blood transfusion services. BJOG 2008;115:1331-9.  Back to cited text no. 4
WHO, UNICEF, UNFP and The World Bank Estimates. Trends in Maternal Mortality: 1990 to 2010. Available from: [Last accessed on 2015 Dec 02].  Back to cited text no. 5
National Blood Transfusion Service, Federal Ministry of Health [Nigeria]. The National Blood Policy. Abuja: National Blood Transfusion Service, Federal Ministry of Health; 2006.  Back to cited text no. 6
Ahmed SG, Ibrahim UA, Hassan AW. Adequacy and pattern of blood donations in North-Eastern Nigeria: The implications for blood safety. Ann Trop Med Parasitol 2007;101:725-31.  Back to cited text no. 7
Osaro E, Charles AT. The challenges of meeting the blood transfusion requirements in sub-Saharan Africa: The need for the development of alternatives to allogenic blood. J Blood Med 2011;2:7-21.  Back to cited text no. 8
Emeribe AO, Ejele AO, Attai EE, Usanga EA. Blood donation and patterns of use in Southeastern Nigeria. Transfusion 1993;33:330-2.  Back to cited text no. 9
Adoga MP, Banwat EB, Forbi JC, Nimzing L, Pam CR, Gyar SD, et al. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: Sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa state, Nigeria. J Infect Dev Ctries 2009;3:539-47.  Back to cited text no. 10
WHO. Universal Access to Safe Blood; 11 February, 2010. Available from: [Last accessed on 2013 Dec 06].  Back to cited text no. 11
Jeremiah ZA, Koate B, Buseri F, Emelike F. Prevalence of antibodies to hepatitis C virus in apparently healthy Port Harcourt blood donors and association with blood groups and other risk indicators. Blood Transfus 2008;6:150-5.  Back to cited text no. 12
Buseri FI, Muhibi MA, Jeremiah ZA. Sero-epidemiology of transfusion-transmissible infectious diseases among blood donors in Osogbo, South-West Nigeria. Blood Transfus 2009;7:293-9.  Back to cited text no. 13
Okocha EC, Aneke JC, Ezeh TU, Ibeh NC, Nwosu GA, Okorie IO, et al. The epidemiology of transfusion-transmissible infections among blood donors in Nnewi, South-East Nigeria. Afr J Med Health Sci 2015;14:125-9.  Back to cited text no. 14
  Medknow Journal  
Allain JP. Moving on from voluntary non-remunerated donors: Who is the best blood donor? Br J Haematol 2011;154:763-9.  Back to cited text no. 15
Kassim OD, Oyekale TO, Aneke JC, Durosinmi MA. Prevalence of seropositive blood donors for hepatitis B, C and HIV viruses at the Federal Medical Centre, Ido-Ekiti, Nigeria. Ann Trop Pathol 2012;3:47-55.  Back to cited text no. 16
Okocha EC, Ejele OA, Ibeh CC, Aneke JC. Prevalence of hepatitis B surface antigen (HBsAg) seropositivity in sickle cell anemia patients in Benin city, mid-Western Nigeria. Ann Trop Pathol 2013;4:83-7.  Back to cited text no. 17
Bolarinwa RA, Aneke JC, Olowookere SA, Salawu L. Seroprevalence of transfusion transmissible viral markers in sickle cell disease patients and healthy controls in Ile-Ife, Southwestern Nigeria: A case-control study. J Appl Hematol 2015;6:162-7.  Back to cited text no. 18
  Medknow Journal  
Olaiya MA, Alakija W, Ajala A, Olatunji RO. Knowledge, attitudes, beliefs and motivations towards blood donations among blood donors in Lagos, Nigeria. Transfus Med 2004;14:13-7.  Back to cited text no. 19
Okpara RA. Attitudes of Nigerians towards blood donation and blood transfusion. Trop Geogr Med 1989;41:89-93.  Back to cited text no. 20
Laperche S. Blood safety and nucleic acid testing in Europe. Euro Surveill 2005;10:3-4.  Back to cited text no. 21
Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE. Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria. Niger J Clin Pract 2015;18:522-6.  Back to cited text no. 22
[PUBMED]  Medknow Journal  
Kangiwa U, Ibegbulam O, Ocheni S, Madu A, Mohammed N. Pattern and prevelence of alloimmunization in multiply transfused patients with sickle cell disease in Nigeria. Biomark Res 2015;3:26.  Back to cited text no. 23
Jeremiah ZA, Mordi A, Buseri FI, Adias TC. Frequencies of maternal red blood cell alloantibodies in Port Harcourt, Nigeria. Asian J Transfus Sci 2011;5:39-41.  Back to cited text no. 24
[PUBMED]  Medknow Journal  
Parker-Williams EJ. Autologous blood transfusion. Postgrad Doct Afr 1989;11:52-6.  Back to cited text no. 25
Adias TC, Jeremiah Z, Uko E, Osaro E. Autologous blood transfusion – A review. S Afr J Surg 2006;44:114-6, 118.  Back to cited text no. 26
Obed JY, Geidam AD, Reuben N. Autologous blood donation and transfusion in obstetrics and gynaecology at the University of Maiduguri Teaching Hospital, Maiduguri, Nigeria. Niger J Clin Pract 2010;13:139-43.  Back to cited text no. 27
[PUBMED]  Medknow Journal  
Babadoko AA, Hassan A, Aminu SM, Dahiru IL, Randawa AJ, Suleiman AM. Autologous blood transfusion in Zaria, Nigeria. Afr Sanguine 2009;12:1. Available from: [Last accessed on 2015 Jan 06].  Back to cited text no. 28
Selo-Ojeme DO, Onwudiegwu U, Durosinmi MA, Owolabi AT. Emergency autologous blood transfusion in the management of ruptured ectopic pregnancy. J Obstet Gynaecol 1997;17:353-5.  Back to cited text no. 29
Amucheazi AO, Ajuzeiogu VO, Ezike HA, Odiakosa MC, Nwoke OM, Onyia E. A survey of blood conservation methods in clinical practice in some urban south-eastern government hospitals in Nigeria. Asian J Transfus Sci 2011;5:35-8.  Back to cited text no. 30
[PUBMED]  Medknow Journal  
Mocini D, Leone T, Tubaro M, Santini M, Penco M. Structure, production and function of erythropoietin: Implications for therapeutical use in cardiovascular disease. Curr Med Chem 2007;14:2278-87.  Back to cited text no. 31
Udosen A, Inyama M, Etiuma A, Urom S, Marwa D. Non-transfusion orthopaedic surgery in complicated fractures among Jehovah's witnesses in Calabar, Nigeria: Case report. Internet J Orthop Surg 2008;11:2. Available from: [Last accessed on 2015 Dec 03].  Back to cited text no. 32
Aminu M, Okachi EE, Abubakar SM, Yahaya A. Prevalence of hepatitis B virus surface antigen among healthy asymptomatic students in a Nigerian University. Ann Afr Med 2013;12:55-6.  Back to cited text no. 33
[PUBMED]  Medknow Journal  
Eke AC, Eke UA, Okafor CI, Ezebialu IU, Ogbuagu C. Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting. Virol J 2011;8:12.  Back to cited text no. 34
Pennap GR, Yakubu A, Oyige O, Forbi J. Prevalence of hepatitis B and C virus infection among people of a local community in Keffi, Nigeria. Afr J Microbiol Res 2010;4:274-8.  Back to cited text no. 35
Ejele OA, Nwauche CA, Erhabor O. Seroprevalence of hepatitis C virus in the Niger Delta of Nigeria. Niger Postgrad Med J 2006;13:103-6.  Back to cited text no. 36
Ophori EA, Atanunu O, Johnny EJ, Adu M. Seroprevalence of syphilis in apparently healthy students from a tertiary institution in Benin city, Nigeria. Jpn J Infect Dis 2010;63:437-9.  Back to cited text no. 37
UNAIDS. Report on the Global AIDS Epidemic; 2008.  Back to cited text no. 38
Bada AS, Olatunji PO, Adewuyi JO, Iseniyi JO, Onile BA. Hepatitis B surface antigenaemia in Ilorin, Kwara state, Nigeria. Cent Afr J Med 1996;42:139-41.  Back to cited text no. 39

Correspondence Address:
John C Aneke
Department of Haematology and Blood Transfusion, Nnamdi Azikiwe University, PMB 5001, Nnewi Campus, Anambra State
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-6247.200781

Rights and Permissions


  [Table 1], [Table 2]

This article has been cited by
1 Reduction in seroprevalence of viral transfusion-transmitted infections in southwest Nigeria in children with sickle cell disease using an enhanced screening strategy
Ann A. Ogbenna, Adeseye M. Akinsete, Olufunto O. Kalejaiye, Oyewole Kunmi Matthew, Deva Sharma, Jennifer Andrews, Adetola A. Kassim
British Journal of Haematology. 2022;
[Pubmed] | [DOI]
2 Trauma provision in South-West Nigeria: Epidemiology, challenges and priorities
Tochukwu Nonso Enemuo
African Journal of Emergency Medicine. 2022; 12(3): 276
[Pubmed] | [DOI]
3 Autotransfusion in low-resource settings: a scoping review
Maria Palmqvist, Johan Von Schreeb, Andreas Älgå
BMJ Open. 2022; 12(5): e056018
[Pubmed] | [DOI]
4 Donor Blood Procurement, Safety, and Clinical Utilization: A Study of Blood Transfusion Services in a Tertiary Care Hospital in Nigeria
Oluomachi Charity Nnachi, Charles Uzor, Chukwuma David Umeokonkwo, Emeka Ogah Onwe, Augustine Ejike Okoye, Richard Lawrence Ewah, Favour Ogonna Nwani, Duran Canatan
Anemia. 2022; 2022: 1
[Pubmed] | [DOI]
5 Effect of the COVID-19 pandemic on blood donations and transfusions in Nigeria – A multi-facility study of 34 tertiary hospitals
A Oreh, T Bozegha, A Ihimekpen, F Biyama, C Irechukwu, S Aliu, D Oshiame, A Nnabuihe, A Ndanitsa, O Nnachi, A Ogbenna, S Abubakar, F Olupitan, A Akinkunmi, C Ogunlade, T Abayomi, U Omokaro, C Sylvester, U Igiebor, B Wokoma, S Ebophni, B Adewuyi, R Dachi, H Muhammad, M Abubakar, J Mgbang, A Chineke, O Ogbuabor, G Fakai, B Hashim, N Adeluwoye, D Olanrewaju, E Agahiu, E Etim, S Alabi, I Akinbola, C Anibueze, O Awogbami, G Edowhorhu, T Adekoya-Benson, S Bello, Y Ojuade, O Amedu
Nigerian Journal of Clinical Practice. 2022; 25(6): 786
[Pubmed] | [DOI]
6 COVID-19 impact on Nigeria's national blood service commission - Lessons for Low- and Middle-Income Countries (LMICs)
AdaezeChidinma Oreh, Christopher Irechukwu, Felix Biyama, Agatha Nnabuihe, Andrew Ihimekpen, Daniel Oshiame, Tariere Bozegha, Ijeoma Leo-Nnadi, Omosigho Izedonmwen, Elton Oga, EneyeJimoh Suberu, Kingsley Odiabara, OmaleJoseph Amedu
Nigerian Postgraduate Medical Journal. 2022; 29(1): 6
[Pubmed] | [DOI]
7 Impact of COVID-19 on blood donation and supply in Africa
Kenneth B. David, Knovicks Simfukwe, Mohamed B. Musa, Steven Munharo, Don E. Lucero-Prisno
African Journal of Laboratory Medicine. 2021; 10(1)
[Pubmed] | [DOI]
8 Snapshot on physicians’ view on safe blood transfusion in multiply transfused patients in Nigeria
ChilotaC Efobi, AngelaO Ugwu, EstherI Obi, EdmundN Ossai, Sunday Ocheni
International Journal of Medicine and Health Development. 2021; 26(1): 50
[Pubmed] | [DOI]
9 A Cross-sectional Study to Analyze Blood and Blood Component Transfusion Practice at Tertiary Care Hospital of Ethiopia
Mahteme Bekele Muleta, Etsehiwot Haileselassie Yisak, Hana Abebe Gebreselassie, Tsega Terefe, Eden Berhanu, Adugna Lissanewerk Mekonnen, Woineshet Alaye, Gizachew Taddesse Akalu, Engida Abebe Gelan, Delayehu Bekele
Clinical Audit. 2021; Volume 13: 29
[Pubmed] | [DOI]
10 Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit
Chris E. Cooper, Matthew Bird, XiaoBo Sheng, Ji-Won Choi, Gary G.A. Silkstone, Michelle Simons, Natalie Syrett, Riccardo Piano, Luca Ronda, Stefano Bettati, Gianluca Paredi, Andrea Mozzarelli, Brandon J. Reeder
Frontiers in Chemistry. 2021; 9
[Pubmed] | [DOI]
Rakesh Kumar Sharma, Shahid Anjum Awan, Vijay Sawhney
[Pubmed] | [DOI]
12 Stroke and stroke prevention in sickle cell anemia in developed and selected developing countries
Pallab Bhattacharya, Deepaneeta Sarmah, Kunjan R. Dave, Avirag Goswami, Mitsuyoshi Watanabe, Xin Wang, Kiran Kalia, Nikolaus Plesnila, Dileep R. Yavagal, Ofelia Alvarez
Journal of the Neurological Sciences. 2021; 427: 117510
[Pubmed] | [DOI]
13 Strategies used in Cameroon blood banks for HIV screening
Elvige Dongmo Geukeng, Anna Longdoh Njunda, Dickson Shey Nsagha, Denis Zofou, Aubin Joseph Nanfack, Joseph Fokam, Nelson Sonela, Annick Ndoumba, Calixte Ida Penda, Françoise Ngo-Sack, Pascal Ngaba, Claude Bertrand Tayou Tagny, Dora Mbanya, Alexis Ndjolo
ISBT Science Series. 2021;
[Pubmed] | [DOI]
14 Knowledge, attitude, and perception towards voluntary blood donation among university students in Nigeria
Sunday Peter Ogundeji, Oluwafemi David Ajayi, Olusogo Ebenezer Busari, Olajumoke A. Ogundeji, Oluwaseun Adewole Adepoju, Folayan GJ Esan
ISBT Science Series. 2021; 16(1): 85
[Pubmed] | [DOI]
15 Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia
Muneer H Albagshi, Mona Saad, Abdulmohsin M Aljassem, Abdulaziz A Bushehab, Noura H Ahmed, Mahmoud M Alabbad, Nawal Omer, Osama A Alhamad, Tarig A Sultan, Samy Bahgat
Cureus. 2021;
[Pubmed] | [DOI]
16 Barriers to Effective Transfusion Practices in Limited-Resource Settings: From Infrastructure to Cultural Beliefs
Alhassan Datti Mohammed, Papytcho Ntambwe, Ana Maria Crawford
World Journal of Surgery. 2020; 44(7): 2094
[Pubmed] | [DOI]
17 Translation of Cryobiological Techniques to Socially Economically Deprived Populations—Part 1: Cryogenic Preservation Strategies
Iryna Buriak, Roland A. Fleck, Anatoliy Goltsev, Nadiya Shevchenko, Maryna Petrushko, Taisiia Yurchuk, Anton Puhovkin, Svitlana Rozanova, Edgardo Elvio Guibert, Maria Celeste Robert, Leonardo Juan de Paz, Matthew J. Powell-Palm, Barry Fuller
Journal of Medical Devices. 2020; 14(1)
[Pubmed] | [DOI]
18 Prevalence of Hepatitis B Surface Antigen and Antibodies to Hepatitis C in the General Population of Benue State, Central Nigeria
Abraham O. Malu, Godwin I. Achinge, Priscilla M. Utoo, Jonathan T. Kur, Solomon A. Obekpa
The American Journal of Tropical Medicine and Hygiene. 2020; 102(5): 995
[Pubmed] | [DOI]
19 Effects of cooperative blood transfusion and homologous blood transfusion on the production of red blood cell irregular antibodies in obstetric patients
Jiguo Liu, Shuyan Wang, Dehou Sha, Jihong Liu, Guangling Cheng
Experimental and Therapeutic Medicine. 2019;
[Pubmed] | [DOI]
20 Prevalence, pattern and clinical implications of transfusion transmissible viral infections among paediatric haemophiliacs in northern Nigeria
Sagir G. Ahmed, Umma A. Ibrahim, Modu B. Kagu
The Journal of Haemophilia Practice. 2018; 5(1): 103
[Pubmed] | [DOI]



    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Email Alert *
    Add to My List *
* Registration required (free)  

    The National Blo...
    Current Status/c...
    Article Tables

 Article Access Statistics
    PDF Downloaded344    
    Comments [Add]    
    Cited by others 20    

Recommend this journal

Association Contact us | Sitemap | Advertise | What's New | Copyright and Disclaimer | Privacy Notice

© 2006 - Asian Journal of Transfusion Science | Published by Wolters Kluwer - Medknow
Online since 10th November, 2006